SlideShare a Scribd company logo
Characterization of Local Vascularization of Transplanted Human Neural Stem
Cell Grafts in the Porcine Spinal Cord
1,2Jason Lamanna, 1Victor Hurtig, 1Elman Amador, 1Juanmarco Gutierrez, 1Lindsey Urquia,
1Thais Federici, and 1,2Nicholas Boulis.
Background: Cell Transplantation in the Spinal Cord
• Clinical trials transplanting cell-based therapeutics into the spinal
cord are underway for a range of neurological diseases, including
Multiple Sclerosis (MS), Spinal Cord Injury (SCI), and Amyotrophic
Lateral Sclerosis (ALS)
• Direct intraparenchymal transplantation has been safely and
effectively utilized by our group in over 150 pigs and 27 clinical
trial subjects (Figure 1)
• Limited information is known about the post-transplantation fate
of cell grafts in clinical trials, including the immunological factors
that impact graft survival
• Immunosuppression regimens in these trials are adapted from
experience with solid organ transplantation
• In pre-clinical studies conducted by our group, we observed a
heterogeneous pattern of cell graft survival between animals and
between individual cell grafts in the same animal
• Understanding the post-transplantation fate of grafted cells is
essential to the widespread clinical translation of cell-based
therapeutics
Objective
The purpose of this study was to quantify host vascularization into transplanted human neural
progenitor cell grafts and correlate this with graft survival in a large animal spinal cord model.
Transplantation and Graft Identification
Funding and References
• Amyotrophic Lateral Sclerosis Association
• Regenerative Engineering and Medicine Center
References
• Klein et al. Human Gene Therapy, 2005
• Riley et al. Neurosurgery, 2009
Vascular Endothelial Growth Factor Expression
Conclusions
Characterization of Vascularization into Transplanted Cell Grafts
1Neurosurgery, Emory University, Atlanta, GA, United States; 2Biomedical Engineering, Emory University & Georgia Institute of Technology, Atlanta, GA, United States
Figure 1: Human intraspinal stem cell
transplantation. Stabilized injection
platform fixated to the spine of a human
clinical trial subject at Emory University.
Human neural stem cells were directly
injected in to the spinal cord (insert).
Transplantation
• Three female Gottingën minipigs underwent a multi-level laminectomy of the thoracolumbar spine,
opening of the dura mater, and placement of a spine-mounted stereotactic injection apparatus
• Twelve 2.5 x 105 cell grafts (25 μL) of human neural progenitor cells (provided by Clive Svendsen at
Cedars Sinai) were directly transplanted into the spinal cord parenchyma
Post-Operative Management
• Pigs were maintained for 6 weeks after transplantation with Tacrolimus (0.025 mg/kg BID IV)
• Daily assessment of sensory and motor function revealed transient, expected post-operative deficits
and full recovery to baseline for all animals within 7 days
Histological Analysis
• Pig were sacrificed 6 weeks after transplantation, spinal cords harvested following transcardiac
perfusion with 4% PFA, and serially sectioned at 50 μm
• Every 6th section was stained for the human nuclear antigen to identify cell grafts
• Stereological quantification of every 6th sectioning using uniform random sampling with the Cavalieri
principle and an optical dissector was performed to calculate individual graft survival
0
20
40
60
80
%Engraftment
200 μm 200 μm
Figure 2. Transplanted Graft Identification and Stereological Quantification. Representative micrographs of transplanted human
neural progenitor cell grafts in the porcine spinal cord with DAB-enhanced human nuclear antigen staining (mouse monoclonal
antibody, MAB1281) with cresyl violet counterstain. A representative non-rejected graft located at the grey/white mater junction with
limited inflammatory infiltrate and over 30% of cells surviving (A). A representative rejected graft from the same animal with less than
5% of cells surviving and a large inflammatory response adjacent to the non-rejected graft (B). The heterogeneity of cell survival of the
36 grafts is apparent with graft-wise stereological quantification (mean 22.0% cell engraftment, range of 0.0 - 65.7%) (C).
A B C
200 μm 200 μm
A
B
0 20 40 60 80
0
2
4
6
8
10
Engraftment %
MicrovascularDensity
r = -0.60, p = 0.0002
D
EC
F
Figure 3. Characterization of Host Vascularization into Transplanted Cell Grafts. The transplanted grafts were identified with human
nuclear antigen staining and cell survival quantified with stereology. Representative micrographs of non-rejected (A) and rejected (C)
grafts are shown. At the center of each graft, co-staining for CD31 (green, mouse monoclonal ab186720) and GFAP (red, rabbit
polyclonal ab7260) was performed. In the representative non-rejected grafts, few large vessels are apparent at low magnification (B).
However, in the rejected graft, numerous infiltrating vessels were apparent (D). Five high-powered fields (E) with the most vessels were
acquired for each graft and average micro-vascular density (MVD) was calculated (mean 18.3 infiltrating vessels per graft, range 3 – 46).
Linear regression showed a statistically significant inverse correlation (r = -0.60, p = 0.0002) between MVD and cell engraftment (F).
CD31 - GFAP - DAPI
• Inverse correlation between host vascularization of transplanted cell grafts and graft survival
• Infiltrating vessels are proliferating, express VEGF and contain numerous immune cells in the
perivascular space
• Studies underway to assess vascular infiltrates of transplanted cell grafts at different time points and
in an allograft model of cell transplantation
• These findings could impact future immunosuppression regimens employed in cell transplantation
Transmission Electron Microscopy and Endothelial Cell
Proliferation
BA Figure 4. Vascular Endothelial Growth Factor
Expression. At the center of transplanted cell grafts, co-
staining for CD31 (green) and VEGF (red, rabbit
polyclonal ab53465) was performed. In low
magnification micrographs, diffuse VEGF expression was
observed in the vessels (A). At higher magnification with
confocal microscopy, VEGF was observed in vascular
endothelial cells and in cells in the perivascular space,
such as T cells (B).
Figure 5. Further Characterization of Infiltrating Vessels.
Transmission Electron Microscopy of cell graft-containing tissue
showed immune cells in the perivascular space of small vessels
not detected with fluorescent microscopy (A, B). Confocal
microscopy of vessels stained for Ki67 (red, ab15580), a marker of
cell proliferation, showed numerous Ki67+ vascular endothelial
cells.
CBA

More Related Content

What's hot

Crispr cas9 in pancreatic cancer
Crispr cas9 in pancreatic cancerCrispr cas9 in pancreatic cancer
Crispr cas9 in pancreatic cancer
IzzxanTanpinarizza
 
Journal of Stem Cells Research, Reviews & Reports
Journal of Stem Cells Research, Reviews & ReportsJournal of Stem Cells Research, Reviews & Reports
Journal of Stem Cells Research, Reviews & Reports
Austin Publishing Group
 
Heraud Et Al. S C R
Heraud Et Al.  S C RHeraud Et Al.  S C R
Heraud Et Al. S C R
uvperson
 
Stem cell therapy in neurological disorder
Stem cell therapy in neurological disorderStem cell therapy in neurological disorder
Stem cell therapy in neurological disorder
NeurologyKota
 
Whartons jelly ms_cs_a4_m
Whartons jelly ms_cs_a4_mWhartons jelly ms_cs_a4_m
Whartons jelly ms_cs_a4_m
ComprehensiveBiologi
 
Role of Stem Cells in Neurosurgery
Role of Stem Cells in NeurosurgeryRole of Stem Cells in Neurosurgery
Role of Stem Cells in Neurosurgery
Amit Agrawal
 
Treatment for lysosomal storage diseases using crispr cas9
Treatment for lysosomal storage diseases using crispr cas9Treatment for lysosomal storage diseases using crispr cas9
Treatment for lysosomal storage diseases using crispr cas9
limchloe
 
Korc Poster Final 11 23 10
Korc Poster Final 11 23 10Korc Poster Final 11 23 10
Korc Poster Final 11 23 10
Jack Crawford
 
Induced Pluripotent Stem Cells and Somatic Cardiac Regeneration— An Explorato...
Induced Pluripotent Stem Cells and Somatic Cardiac Regeneration— An Explorato...Induced Pluripotent Stem Cells and Somatic Cardiac Regeneration— An Explorato...
Induced Pluripotent Stem Cells and Somatic Cardiac Regeneration— An Explorato...
Robert Chen
 
Seminario Biologia Molecular
Seminario Biologia Molecular Seminario Biologia Molecular
Seminario Biologia Molecular
katerinaruiz
 
Stem cells and regenerative medicine
Stem cells and regenerative medicineStem cells and regenerative medicine
Stem cells and regenerative medicine
JibanjyotiDas2
 
2008-0471S1-4
2008-0471S1-42008-0471S1-4
2008-0471S1-4pharmdude
 
Stem cell research
Stem cell researchStem cell research
Stem cell research
Tariq Mohammed
 
Ct 1074 williams-et_al_1382453246153
Ct 1074 williams-et_al_1382453246153Ct 1074 williams-et_al_1382453246153
Ct 1074 williams-et_al_1382453246153
Vasili Smahlei
 
Peripheral neuropathyumbilicalcord
Peripheral neuropathyumbilicalcordPeripheral neuropathyumbilicalcord
Peripheral neuropathyumbilicalcord
ComprehensiveBiologi
 
Neuromics presentation november 2021
Neuromics presentation november 2021Neuromics presentation november 2021
Neuromics presentation november 2021
Pete Shuster
 
Cartilage Repair using Stem cell & Orthobiologics
Cartilage Repair using Stem cell & OrthobiologicsCartilage Repair using Stem cell & Orthobiologics
Cartilage Repair using Stem cell & Orthobiologics
Vaibhav Bagaria
 

What's hot (20)

Crispr cas9 in pancreatic cancer
Crispr cas9 in pancreatic cancerCrispr cas9 in pancreatic cancer
Crispr cas9 in pancreatic cancer
 
Journal of Stem Cells Research, Reviews & Reports
Journal of Stem Cells Research, Reviews & ReportsJournal of Stem Cells Research, Reviews & Reports
Journal of Stem Cells Research, Reviews & Reports
 
Heraud Et Al. S C R
Heraud Et Al.  S C RHeraud Et Al.  S C R
Heraud Et Al. S C R
 
1.3 df
1.3 df1.3 df
1.3 df
 
1.2 fpr
1.2 fpr1.2 fpr
1.2 fpr
 
Stem cell therapy in neurological disorder
Stem cell therapy in neurological disorderStem cell therapy in neurological disorder
Stem cell therapy in neurological disorder
 
Whartons jelly ms_cs_a4_m
Whartons jelly ms_cs_a4_mWhartons jelly ms_cs_a4_m
Whartons jelly ms_cs_a4_m
 
Role of Stem Cells in Neurosurgery
Role of Stem Cells in NeurosurgeryRole of Stem Cells in Neurosurgery
Role of Stem Cells in Neurosurgery
 
Treatment for lysosomal storage diseases using crispr cas9
Treatment for lysosomal storage diseases using crispr cas9Treatment for lysosomal storage diseases using crispr cas9
Treatment for lysosomal storage diseases using crispr cas9
 
Korc Poster Final 11 23 10
Korc Poster Final 11 23 10Korc Poster Final 11 23 10
Korc Poster Final 11 23 10
 
Induced Pluripotent Stem Cells and Somatic Cardiac Regeneration— An Explorato...
Induced Pluripotent Stem Cells and Somatic Cardiac Regeneration— An Explorato...Induced Pluripotent Stem Cells and Somatic Cardiac Regeneration— An Explorato...
Induced Pluripotent Stem Cells and Somatic Cardiac Regeneration— An Explorato...
 
Seminario Biologia Molecular
Seminario Biologia Molecular Seminario Biologia Molecular
Seminario Biologia Molecular
 
Stem cells and regenerative medicine
Stem cells and regenerative medicineStem cells and regenerative medicine
Stem cells and regenerative medicine
 
2008-0471S1-4
2008-0471S1-42008-0471S1-4
2008-0471S1-4
 
Stem cell research
Stem cell researchStem cell research
Stem cell research
 
Ct 1074 williams-et_al_1382453246153
Ct 1074 williams-et_al_1382453246153Ct 1074 williams-et_al_1382453246153
Ct 1074 williams-et_al_1382453246153
 
Peripheral neuropathyumbilicalcord
Peripheral neuropathyumbilicalcordPeripheral neuropathyumbilicalcord
Peripheral neuropathyumbilicalcord
 
Neuromics presentation november 2021
Neuromics presentation november 2021Neuromics presentation november 2021
Neuromics presentation november 2021
 
Cartilage Repair using Stem cell & Orthobiologics
Cartilage Repair using Stem cell & OrthobiologicsCartilage Repair using Stem cell & Orthobiologics
Cartilage Repair using Stem cell & Orthobiologics
 
PSN poster
PSN posterPSN poster
PSN poster
 

Similar to Vascular_Poster

Stem cell therapy neurological disorders
Stem cell therapy neurological disordersStem cell therapy neurological disorders
Stem cell therapy neurological disorders
NeurologyKota
 
Administration of Autologous Bone Marrow Stem Cells Into Spinal Cord Injury P...
Administration of Autologous Bone Marrow Stem Cells Into Spinal Cord Injury P...Administration of Autologous Bone Marrow Stem Cells Into Spinal Cord Injury P...
Administration of Autologous Bone Marrow Stem Cells Into Spinal Cord Injury P...
◂ Justin (M) Gaines ▸
 
(February 16, 2023) Webinar: Intracerebral Transplantation of Autologous Bone...
(February 16, 2023) Webinar: Intracerebral Transplantation of Autologous Bone...(February 16, 2023) Webinar: Intracerebral Transplantation of Autologous Bone...
(February 16, 2023) Webinar: Intracerebral Transplantation of Autologous Bone...
Scintica Instrumentation
 
079 monocyte recruitment into atherosclerotic plaques
079 monocyte recruitment into atherosclerotic plaques079 monocyte recruitment into atherosclerotic plaques
079 monocyte recruitment into atherosclerotic plaques
SHAPE Society
 
Paludisme grave : pourquoi doit-on développer des modèles in vitro sur le ter...
Paludisme grave : pourquoi doit-on développer des modèles in vitro sur le ter...Paludisme grave : pourquoi doit-on développer des modèles in vitro sur le ter...
Paludisme grave : pourquoi doit-on développer des modèles in vitro sur le ter...
Institut Pasteur de Madagascar
 
2015_Postdoc_symposium_poster
2015_Postdoc_symposium_poster2015_Postdoc_symposium_poster
2015_Postdoc_symposium_posterChi Y. Lo, Ph.D.
 
LncRNA WARS2-IT1 Functions as an Oncogene and is Associated with Poor Outcome...
LncRNA WARS2-IT1 Functions as an Oncogene and is Associated with Poor Outcome...LncRNA WARS2-IT1 Functions as an Oncogene and is Associated with Poor Outcome...
LncRNA WARS2-IT1 Functions as an Oncogene and is Associated with Poor Outcome...
semualkaira
 
LncRNA WARS2-IT1 Functions as an Oncogene and is Associated with Poor Outcome...
LncRNA WARS2-IT1 Functions as an Oncogene and is Associated with Poor Outcome...LncRNA WARS2-IT1 Functions as an Oncogene and is Associated with Poor Outcome...
LncRNA WARS2-IT1 Functions as an Oncogene and is Associated with Poor Outcome...
semualkaira
 
LncRNA WARS2-IT1 Functions as an Oncogene and is Associated with Poor Outcome...
LncRNA WARS2-IT1 Functions as an Oncogene and is Associated with Poor Outcome...LncRNA WARS2-IT1 Functions as an Oncogene and is Associated with Poor Outcome...
LncRNA WARS2-IT1 Functions as an Oncogene and is Associated with Poor Outcome...
semualkaira
 
Singapore conference 2015 jj
Singapore conference  2015 jjSingapore conference  2015 jj
Singapore conference 2015 jj
Global R & D Services
 
Stemcell Therapy in Neurosurgery
Stemcell Therapy in NeurosurgeryStemcell Therapy in Neurosurgery
Stemcell Therapy in Neurosurgery
PGINeurosurgery
 
Stem Cells - Biology ppt slides
Stem Cells - Biology ppt slidesStem Cells - Biology ppt slides
Stem Cells - Biology ppt slides
nihattt
 
Abstract - 2015 Hawaii Conference
Abstract - 2015 Hawaii ConferenceAbstract - 2015 Hawaii Conference
Abstract - 2015 Hawaii ConferenceElman Amador
 
Autologous Bone Marrow Cell Therapy for Autism: An Open Label Uncontrolled C...
Autologous Bone Marrow Cell Therapy for Autism: An  Open Label Uncontrolled C...Autologous Bone Marrow Cell Therapy for Autism: An  Open Label Uncontrolled C...
Autologous Bone Marrow Cell Therapy for Autism: An Open Label Uncontrolled C...
remedypublications2
 
Induced Pluripotent Stem Cell & Cell Dedifferentiation: The Breakthrough of S...
Induced Pluripotent Stem Cell & Cell Dedifferentiation: The Breakthrough of S...Induced Pluripotent Stem Cell & Cell Dedifferentiation: The Breakthrough of S...
Induced Pluripotent Stem Cell & Cell Dedifferentiation: The Breakthrough of S...
Vincentsia Vienna
 
Stem cell therapy in neurological disorder
Stem cell therapy in neurological disorder  Stem cell therapy in neurological disorder
Stem cell therapy in neurological disorder
NeurologyKota
 
Autologous Bone Marrow Mononuclear Cell Therapy for Autism: An Open Label Pro...
Autologous Bone Marrow Mononuclear Cell Therapy for Autism: An Open Label Pro...Autologous Bone Marrow Mononuclear Cell Therapy for Autism: An Open Label Pro...
Autologous Bone Marrow Mononuclear Cell Therapy for Autism: An Open Label Pro...
DrAlokSharma
 

Similar to Vascular_Poster (20)

Stem cell therapy neurological disorders
Stem cell therapy neurological disordersStem cell therapy neurological disorders
Stem cell therapy neurological disorders
 
Administration of Autologous Bone Marrow Stem Cells Into Spinal Cord Injury P...
Administration of Autologous Bone Marrow Stem Cells Into Spinal Cord Injury P...Administration of Autologous Bone Marrow Stem Cells Into Spinal Cord Injury P...
Administration of Autologous Bone Marrow Stem Cells Into Spinal Cord Injury P...
 
(February 16, 2023) Webinar: Intracerebral Transplantation of Autologous Bone...
(February 16, 2023) Webinar: Intracerebral Transplantation of Autologous Bone...(February 16, 2023) Webinar: Intracerebral Transplantation of Autologous Bone...
(February 16, 2023) Webinar: Intracerebral Transplantation of Autologous Bone...
 
Monocyte recruitment into atherosclerotic plaques
Monocyte recruitment into atherosclerotic plaquesMonocyte recruitment into atherosclerotic plaques
Monocyte recruitment into atherosclerotic plaques
 
079 monocyte recruitment into atherosclerotic plaques
079 monocyte recruitment into atherosclerotic plaques079 monocyte recruitment into atherosclerotic plaques
079 monocyte recruitment into atherosclerotic plaques
 
079 monocyte recruitment into atherosclerotic plaques
079 monocyte recruitment into atherosclerotic plaques079 monocyte recruitment into atherosclerotic plaques
079 monocyte recruitment into atherosclerotic plaques
 
Paludisme grave : pourquoi doit-on développer des modèles in vitro sur le ter...
Paludisme grave : pourquoi doit-on développer des modèles in vitro sur le ter...Paludisme grave : pourquoi doit-on développer des modèles in vitro sur le ter...
Paludisme grave : pourquoi doit-on développer des modèles in vitro sur le ter...
 
2015_Postdoc_symposium_poster
2015_Postdoc_symposium_poster2015_Postdoc_symposium_poster
2015_Postdoc_symposium_poster
 
LncRNA WARS2-IT1 Functions as an Oncogene and is Associated with Poor Outcome...
LncRNA WARS2-IT1 Functions as an Oncogene and is Associated with Poor Outcome...LncRNA WARS2-IT1 Functions as an Oncogene and is Associated with Poor Outcome...
LncRNA WARS2-IT1 Functions as an Oncogene and is Associated with Poor Outcome...
 
LncRNA WARS2-IT1 Functions as an Oncogene and is Associated with Poor Outcome...
LncRNA WARS2-IT1 Functions as an Oncogene and is Associated with Poor Outcome...LncRNA WARS2-IT1 Functions as an Oncogene and is Associated with Poor Outcome...
LncRNA WARS2-IT1 Functions as an Oncogene and is Associated with Poor Outcome...
 
LncRNA WARS2-IT1 Functions as an Oncogene and is Associated with Poor Outcome...
LncRNA WARS2-IT1 Functions as an Oncogene and is Associated with Poor Outcome...LncRNA WARS2-IT1 Functions as an Oncogene and is Associated with Poor Outcome...
LncRNA WARS2-IT1 Functions as an Oncogene and is Associated with Poor Outcome...
 
Singapore conference 2015 jj
Singapore conference  2015 jjSingapore conference  2015 jj
Singapore conference 2015 jj
 
Stemcell Therapy in Neurosurgery
Stemcell Therapy in NeurosurgeryStemcell Therapy in Neurosurgery
Stemcell Therapy in Neurosurgery
 
Stem Cells - Biology ppt slides
Stem Cells - Biology ppt slidesStem Cells - Biology ppt slides
Stem Cells - Biology ppt slides
 
Abstract - 2015 Hawaii Conference
Abstract - 2015 Hawaii ConferenceAbstract - 2015 Hawaii Conference
Abstract - 2015 Hawaii Conference
 
Autologous Bone Marrow Cell Therapy for Autism: An Open Label Uncontrolled C...
Autologous Bone Marrow Cell Therapy for Autism: An  Open Label Uncontrolled C...Autologous Bone Marrow Cell Therapy for Autism: An  Open Label Uncontrolled C...
Autologous Bone Marrow Cell Therapy for Autism: An Open Label Uncontrolled C...
 
Induced Pluripotent Stem Cell & Cell Dedifferentiation: The Breakthrough of S...
Induced Pluripotent Stem Cell & Cell Dedifferentiation: The Breakthrough of S...Induced Pluripotent Stem Cell & Cell Dedifferentiation: The Breakthrough of S...
Induced Pluripotent Stem Cell & Cell Dedifferentiation: The Breakthrough of S...
 
Stem cell therapy in neurological disorder
Stem cell therapy in neurological disorder  Stem cell therapy in neurological disorder
Stem cell therapy in neurological disorder
 
-28th ISPSR POSTER
-28th ISPSR POSTER-28th ISPSR POSTER
-28th ISPSR POSTER
 
Autologous Bone Marrow Mononuclear Cell Therapy for Autism: An Open Label Pro...
Autologous Bone Marrow Mononuclear Cell Therapy for Autism: An Open Label Pro...Autologous Bone Marrow Mononuclear Cell Therapy for Autism: An Open Label Pro...
Autologous Bone Marrow Mononuclear Cell Therapy for Autism: An Open Label Pro...
 

Vascular_Poster

  • 1. Characterization of Local Vascularization of Transplanted Human Neural Stem Cell Grafts in the Porcine Spinal Cord 1,2Jason Lamanna, 1Victor Hurtig, 1Elman Amador, 1Juanmarco Gutierrez, 1Lindsey Urquia, 1Thais Federici, and 1,2Nicholas Boulis. Background: Cell Transplantation in the Spinal Cord • Clinical trials transplanting cell-based therapeutics into the spinal cord are underway for a range of neurological diseases, including Multiple Sclerosis (MS), Spinal Cord Injury (SCI), and Amyotrophic Lateral Sclerosis (ALS) • Direct intraparenchymal transplantation has been safely and effectively utilized by our group in over 150 pigs and 27 clinical trial subjects (Figure 1) • Limited information is known about the post-transplantation fate of cell grafts in clinical trials, including the immunological factors that impact graft survival • Immunosuppression regimens in these trials are adapted from experience with solid organ transplantation • In pre-clinical studies conducted by our group, we observed a heterogeneous pattern of cell graft survival between animals and between individual cell grafts in the same animal • Understanding the post-transplantation fate of grafted cells is essential to the widespread clinical translation of cell-based therapeutics Objective The purpose of this study was to quantify host vascularization into transplanted human neural progenitor cell grafts and correlate this with graft survival in a large animal spinal cord model. Transplantation and Graft Identification Funding and References • Amyotrophic Lateral Sclerosis Association • Regenerative Engineering and Medicine Center References • Klein et al. Human Gene Therapy, 2005 • Riley et al. Neurosurgery, 2009 Vascular Endothelial Growth Factor Expression Conclusions Characterization of Vascularization into Transplanted Cell Grafts 1Neurosurgery, Emory University, Atlanta, GA, United States; 2Biomedical Engineering, Emory University & Georgia Institute of Technology, Atlanta, GA, United States Figure 1: Human intraspinal stem cell transplantation. Stabilized injection platform fixated to the spine of a human clinical trial subject at Emory University. Human neural stem cells were directly injected in to the spinal cord (insert). Transplantation • Three female Gottingën minipigs underwent a multi-level laminectomy of the thoracolumbar spine, opening of the dura mater, and placement of a spine-mounted stereotactic injection apparatus • Twelve 2.5 x 105 cell grafts (25 μL) of human neural progenitor cells (provided by Clive Svendsen at Cedars Sinai) were directly transplanted into the spinal cord parenchyma Post-Operative Management • Pigs were maintained for 6 weeks after transplantation with Tacrolimus (0.025 mg/kg BID IV) • Daily assessment of sensory and motor function revealed transient, expected post-operative deficits and full recovery to baseline for all animals within 7 days Histological Analysis • Pig were sacrificed 6 weeks after transplantation, spinal cords harvested following transcardiac perfusion with 4% PFA, and serially sectioned at 50 μm • Every 6th section was stained for the human nuclear antigen to identify cell grafts • Stereological quantification of every 6th sectioning using uniform random sampling with the Cavalieri principle and an optical dissector was performed to calculate individual graft survival 0 20 40 60 80 %Engraftment 200 μm 200 μm Figure 2. Transplanted Graft Identification and Stereological Quantification. Representative micrographs of transplanted human neural progenitor cell grafts in the porcine spinal cord with DAB-enhanced human nuclear antigen staining (mouse monoclonal antibody, MAB1281) with cresyl violet counterstain. A representative non-rejected graft located at the grey/white mater junction with limited inflammatory infiltrate and over 30% of cells surviving (A). A representative rejected graft from the same animal with less than 5% of cells surviving and a large inflammatory response adjacent to the non-rejected graft (B). The heterogeneity of cell survival of the 36 grafts is apparent with graft-wise stereological quantification (mean 22.0% cell engraftment, range of 0.0 - 65.7%) (C). A B C 200 μm 200 μm A B 0 20 40 60 80 0 2 4 6 8 10 Engraftment % MicrovascularDensity r = -0.60, p = 0.0002 D EC F Figure 3. Characterization of Host Vascularization into Transplanted Cell Grafts. The transplanted grafts were identified with human nuclear antigen staining and cell survival quantified with stereology. Representative micrographs of non-rejected (A) and rejected (C) grafts are shown. At the center of each graft, co-staining for CD31 (green, mouse monoclonal ab186720) and GFAP (red, rabbit polyclonal ab7260) was performed. In the representative non-rejected grafts, few large vessels are apparent at low magnification (B). However, in the rejected graft, numerous infiltrating vessels were apparent (D). Five high-powered fields (E) with the most vessels were acquired for each graft and average micro-vascular density (MVD) was calculated (mean 18.3 infiltrating vessels per graft, range 3 – 46). Linear regression showed a statistically significant inverse correlation (r = -0.60, p = 0.0002) between MVD and cell engraftment (F). CD31 - GFAP - DAPI • Inverse correlation between host vascularization of transplanted cell grafts and graft survival • Infiltrating vessels are proliferating, express VEGF and contain numerous immune cells in the perivascular space • Studies underway to assess vascular infiltrates of transplanted cell grafts at different time points and in an allograft model of cell transplantation • These findings could impact future immunosuppression regimens employed in cell transplantation Transmission Electron Microscopy and Endothelial Cell Proliferation BA Figure 4. Vascular Endothelial Growth Factor Expression. At the center of transplanted cell grafts, co- staining for CD31 (green) and VEGF (red, rabbit polyclonal ab53465) was performed. In low magnification micrographs, diffuse VEGF expression was observed in the vessels (A). At higher magnification with confocal microscopy, VEGF was observed in vascular endothelial cells and in cells in the perivascular space, such as T cells (B). Figure 5. Further Characterization of Infiltrating Vessels. Transmission Electron Microscopy of cell graft-containing tissue showed immune cells in the perivascular space of small vessels not detected with fluorescent microscopy (A, B). Confocal microscopy of vessels stained for Ki67 (red, ab15580), a marker of cell proliferation, showed numerous Ki67+ vascular endothelial cells. CBA